Immunos Therapeutics
Series AImmunos Therapeutics raised €14M in a Series A round in Oct 2019. The company is based in Schlieren, Switzerland. Investors in the round: BioMedPartners, Pfizer Ventures. Data as of Nov 2026.
Amount raised
€14M
€13,828,708
Native amount
15,000,000 CHF
Stage
Series A
series a
Investors
2
Provenance & confidence
High confidenceAmount
15,000,000 CHF
ECB-at-date → €14M · rate 1.0847 on 2019-09-30
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Oct 2019
Round type
series a
Amount (EUR)
€14M